Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases DiagnosisReview Published on 2020-05-262022-10-30 Journal: Nanomaterials [Category] COVID-19, [키워드] applied Autoimmune Biomarker biopsy Cancer circulating circulating nucleic acids circulating tumor cells coronavirus disease COVID-19 COVID-19 diagnosis Diagnosis Diseases early diagnosis Exosomes Graphene liquid liquid biopsy neurodegenerative disorders nucleic acids optical Perspective platform scattering SERS Strategy syndrome therapy tumor cells Viral diseases [DOI] 10.3390/nano10061014 PMC 바로가기 [Article Type] Review
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demiseReview Published on 2020-05-262022-10-31 Journal: Future Virology [Category] COVID-19, [키워드] acute respiratory distress acute respiratory syndrome approach Cancer Coronavirus-2 COVID-19 demise effort furin GM-CSF immune response infected patients management phase Plasmid Prophylactic SARS-CoV-2 syndrome therapeutic Treatment trials Vaccine development vigil virus [DOI] 10.2217/fvl-2020-0068 PMC 바로가기 [Article Type] Review
Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaborationCorrespondence Published on 2020-05-252022-10-31 Journal: ESMO open [Category] COVID-19, MERS, SARS, [키워드] Cancer COVID-19 dataset principles the SARS-CoV-2 [DOI] 10.1136/esmoopen-2020-000825 PMC 바로가기 [Article Type] Correspondence
Acute Respiratory Failure Secondary to COVID-19 Viral Pneumonia Managed With Hydroxychloroquine/Azithromycin TreatmentAnesthesiology Published on 2020-05-252022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Acute respiratory failure Admission age Antiviral treatment Azithromycin Cancer Case report center cerebrovascular accident Chest Combination Comorbidities coronavirus disease COVID-19 Day Department Diabetes Mellitus Effectiveness Evidence failure highest Hydroxychloroquine hypertension ICU intensive care unit intubation lung male Mortality neurological deficits New York patchy Patient positive provide respiratory Respiratory failure returned risk secondary to Septic shock significantly sputum state tomography university Vaccine Vascular Viral pneumonia [DOI] 10.7759/cureus.8268 PMC 바로가기 [Article Type] Anesthesiology
Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and CareOncology Published on 2020-05-222022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] Cancer clinical trial Conducting COVI-19 phase Phase I (drug development) SARS - CoV-2 Science [DOI] 10.3389/fonc.2020.00926 PMC 바로가기 [Article Type] Oncology
Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours GroupReview Published on 2020-05-222022-10-31 Journal: ecancermedicalscience [Category] COVID-19, [키워드] advanced age Anal approach Cancer cancer patient Cancer patients caused coronavirus Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19 patients decrease diabete Evidence Follow-up Gastrointestinal gastrointestinal tumours group Guidance Health health systems hepatocellular high risk hospital resource include individual infect lack malignancies management neuroendocrine outcome overall mortality pancreas pandemic Patient pulmonary diseases Radiotherapy recommendation resource Result risk factor risk of COVID-19 SARS CoV-2 severe complication surgical the SARS-CoV-2 virus treat Treatment Tumours virulent virus while [DOI] 10.3332/ecancer.2020.1048 PMC 바로가기 [Article Type] Review
A Primary Mediastinal Large B-Cell Lymphoma Patient With COVID-19 Infection After Intensive Immunochemotherapy: A Case ReportOncology Published on 2020-05-222022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] anti-cancer treatment Antibiotics Arbidol B-cell lymphoma Cancer Chemotherapy Chest CT coronavirus disease COVID-19 COVID-19 infection cured dose intensity Epidemic Evidence Fever General population global public health hydrochloride Immune status Immunotherapy Impact infected with COVID-19 Intensive knowledge lymphoma myelosuppression outbreak Patient Pneumonia reduced report subtype the patient throat swab treated Treatment were used [DOI] 10.3389/fonc.2020.00924 PMC 바로가기 [Article Type] Oncology
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) Reviews Published on 2020-05-222022-10-05 Journal: Leukemia [Category] SARS, 유전자 메커니즘, 임상, [키워드] Administered Allogeneic biochemical bortezomib Cancer Cell clinical trial Community Comorbidities Complication Consensus consensus paper country COVID-19 COVID-19 infection COVID-19 pandemic Dexamethasone disease drug interaction early diagnosis end organ damage European event Hospital admission hygiene Immunocompromised increased risk infections International Local Multiple myeloma Myeloma Nasopharyngeal swab network no symptom Older age oral Patient Patient education PCR test positive PCR test provided quarantine regimen risk SARS-CoV-2 Severe COVID-19 Infection social distancing measures Spread Surveillance symptomatic COVID-19 disease therapeutic decision Treatment [DOI] 10.1038/s41375-020-0876-z [Article Type] Reviews
Influence of the pandemic dissemination of COVID-19 on radiotherapy practice: A flash survey in Germany, Austria and SwitzerlandResearch Article Published on 2020-05-212022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] affected All participant analysed Cancer changed conducted COVID-19 COVID-19 dissemination COVID-19 pandemic dissemination Effect Germany high risk hospitals increasingly Infection influence information initial intensive care unit management Measures pandemic Patient Radiotherapy reduction response Result risk Support Switzerland [DOI] 10.1371/journal.pone.0233330 PMC 바로가기 [Article Type] Research Article
COVID 19 therapies and anti-cancer drugs: A systematic review of recent literatureArticle Published on 2020-05-212024-09-04 Journal: Critical Reviews in Oncology/Hematology [Category] 대상포진, [키워드] antiviral therapy Cancer Coronavirus disease SARS-CoV-2 (COVID-19) Drug-interactions management [DOI] 10.1016/j.critrevonc.2020.102991 PMC 바로가기 [Article Type] Article